恩华药业

- 002262

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015 
恩华药业(002262) 利润表
单位:万元
报表日期2025-03-312024-12-312024-09-302024-06-302024-03-31
一、营业总收入151,088.88569,763.30414,546.31276,339.81135,756.57
营业收入151,088.88569,763.30414,546.31276,339.81135,756.57
二、营业总成本117,250.79440,387.22299,590.86203,408.29103,680.83
营业成本38,239.43150,654.09108,807.2675,996.7139,670.69
营业税金及附加1,879.367,529.485,409.393,678.171,867.19
销售费用50,832.47198,474.67125,156.9982,972.1843,702.81
管理费用7,411.9825,876.1717,866.8911,489.474,733.73
财务费用-313.41-1,712.68-1,216.66-878.38-635.57
研发费用19,200.9659,565.5043,566.9930,150.1414,341.99
资产减值损失----------
公允价值变动收益----------
投资收益2,073.256,556.864,337.602,085.191,138.71
其中:对联营企业和合营企业的投资收益264.332,028.93684.94343.03421.71
汇兑收益----------
三、营业利润33,860.21133,657.36117,139.3473,255.3830,487.13
加:营业外收入24.54465.40256.02184.41182.28
减:营业外支出251.634,453.922,155.541,340.54695.80
其中:非流动资产处置损失----------
四、利润总额33,633.12129,668.84115,239.8372,099.2529,973.61
减:所得税费用3,569.1515,589.6113,586.119,441.893,509.74
五、净利润30,063.96114,079.23101,653.7262,657.3626,463.88
归属于母公司所有者的净利润30,070.57114,356.44102,010.7162,892.0326,528.22
少数股东损益-6.61-277.21-356.99-234.67-64.35
六、每股收益
基本每股收益(元/股)0.30001.13001.01000.62000.2600
稀释每股收益(元/股)0.30001.13001.01000.62000.2600
七、其他综合收益---588.12------
八、综合收益总额30,063.96113,491.11101,653.7262,657.3626,463.88
归属于母公司所有者的综合收益总额30,070.57113,768.33102,010.7162,892.0326,528.22
归属于少数股东的综合收益总额-6.61-277.21-356.99-234.67-64.35
下载全部历史数据到excel中 返回页顶